Venous thromboembolism - dabigatran (TA157)
Fast, easy summary view of NICE guidance on 'venous thromboembolism'
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults
Dabigatran etexilate is recommended as a possible treatment to reduce the risk of venous thromboembolism in adults who have surgery to replace their hip or knee joint.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: venous thromboembolism
This page was last updated: 30 July 2013
- Web format
- Quick reference guide (PDF)
- Full Guidance (PDF)
- TA157 Dabigatran etexilate i leihau'r risg o thrombo-emboledd gwythiennol ar ôl llawdriniaeth i osod clun neu ben-glin newydd: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.